Sagent Pharmaceuticals (SGNT) Misses Q2 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Sagent Pharmaceuticals Reports Second Quarter 2015 Financial Results
August 4, 2015 7:00 AM EDTCompany to evaluate strategic alternatives for Sagent (China) Pharmaceuticals
Company modifies earnings guidance for 2015
SCHAUMBURG, Ill., Aug. 4, 2015 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (NASDAQ: SGNT), a leader of specialty pharmaceutical products with a specific emphasis on the injectable market, today announced financial results for the quarter ended June 30, 2015.
Second Quarter 2015 Highlights
Revenue increased 12% to $77.3 million driven primarily by the October 1, 2014 acquisition of Omega Laboratories Limited ("Omega"); Reported gross profit declined 18% to $18.4 million, or 23.8% of net revenue;... MoreSagent Pharmaceuticals Board Appoints Allan Oberman as Chief Executive Officer
August 3, 2015 4:25 PM EDTSCHAUMBURG, Ill., Aug. 3, 2015 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (NASDAQ: SGNT) a leader of specialty pharmaceutical products with a specific emphasis on the injectables market, today announced that its Board of Directors has named Allan Oberman as Chief Executive Officer and a member of the Board of Directors, effective immediately upon receipt of a US work visa.
"Allan is a proven leader with impeccable credentials and strategic instincts that will serve Sagent well as we enter our next phase of growth," said Robert J. Flanagan, Chairman of Sagent's Board of Directors. "Allan... More
